ESSA PHARMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | -.--% |
| 05-20 | Top Premarket Decliners | MT |
| 05-14 | ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
Volumes
marketsDaily volume
0
Record volume 1
0
Record volume 2
0
Record volume 3
0
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
408 359 729
Capitalization (USD)
299 450 189
Net sales (CAD)
0
Net sales (USD)
0
Number of employees
50
Sales / Employee (CAD)
0
Sales / Employee (USD)
0
Free-Float
97.73 %
Free-Float capitalization (CAD)
399 088 912
Free-Float capitalization (USD)
292 651 900
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 299M | ||
| -5.89% | -14.43% | +43.36% | +10.93% | 54.63B | ||
| -1.51% | -4.58% | -5.31% | +10.11% | 39.92B | ||
| +0.59% | +1.28% | +14.75% | +50.48% | 26.86B | ||
| -0.62% | -2.06% | -12.56% | +0.46% | 26.22B | ||
| -1.07% | +0.45% | -22.45% | -21.33% | 18.78B | ||
| +1.73% | +0.82% | +25.12% | +28.88% | 12.21B | ||
| -0.08% | -4.46% | +0.04% | -5.51% | 12.16B | ||
| +0.17% | -1.08% | +26.04% | +86.74% | 11.94B | ||
| -0.61% | -4.04% | -11.83% | +6.16% | 10.74B | ||
| +1.45% | -1.07% | -3.38% | -8.34% | 9.6B | ||
| -1.82% | -6.48% | +24.38% | -13.99% | 6.71B | ||
| -0.75% | +2.67% | +14.44% | +85.88% | 6.61B | ||
| +0.42% | +1.00% | +33.65% | +52.10% | 6.32B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +0.19% | -1.78% | -1.89% | -34.55% | 6.03B | ||
| Average | -0.49% | -2.29% | +8.88% | +17.72% | ||
| Weighted average by Cap. | -1.51% | -4.41% | +10.94% | +15.56% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
- Stock Market
- Equities
- EPIX Stock
- Stock
- Quotes ESSA Pharma Inc.
